earlier than emtricitabine Generic Name: emtricitabine (em trye SYE ta been) Brand Name: Emtriva Overview Side Effects Dosage Professional Interactions More Pregnancy Warnings Breastfeeding Warnings User Reviews Support Group Q & A What is emtricitabine? Emtricitabine is an antiviral medicine that prevents human immunodeficiency virus (HIV) from multiplying in your body. Emtricitabine is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). Emtricitabine is not a cure for HIV or AIDS. Emtricitabine may also be used for purposes not listed in this medication guide. Slideshow 2016 New Drug Approvals: The Year That Was What is the most important information I should know about emtricitabine? Do not take Emtriva if you also take other medicines that contain emtricitabine or lamivudine. Emtricitabine may cause a serious condition called lactic acidosis. Get emergency medical help if you have even mild symptoms such as: muscle pain or weakness, numb or cold feeling in your arms and legs, trouble breathing, stomach pain, nausea with vomiting, fast or uneven heart rate, dizziness, or feeling very weak or tired. If you have hepatitis B you may develop liver symptoms after you stop taking emtricitabine, even months after stopping. What should I discuss with my healthcare provider before taking emtricitabine? You should not take this medicine if you are allergic to emtricitabine. Do not take Emtriva if you also use other medicines that contain emtricitabine or lamivudine (such as Atripla, Combivir, Complera, Descovy, Dutrebis, Epivir, Epzicom, Genvoya, Odefsey, Stribild, Triumeq, or Trizivir). To make sure emtricitabine is safe for you, tell your doctor if you have ever had: liver disease (especially hepatitis B); or kidney disease. Some people taking this medicine develop a serious condition called lactic acidosis. This may be more likely in women, in people who are overweight or have liver disease, and in people who have taken HIV/AIDS medication for a long time. Talk with your doctor about your risk. HIV can be passed to your baby if you are not properly treated during pregnancy. Take all of your HIV medicines as directed to control your infection. If you are pregnant, your name may be listed on a pregnancy registry. This is to track the outcome of the pregnancy and to evaluate any effects of emtricitabine on the baby. Women with HIV or AIDS should not breast-feed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk. Emtricitabine is not approved for use by anyone younger than 3 months old. How should I take emtricitabine? Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended. Emtricitabine can be taken with or without food. Measure liquid medicine with the dosing syringe provided, or with a special dose-measuring spoon or medicine cup. If you do not have a dose-measuring device, ask your pharmacist for one. If a child is using this medicine, tell your doctor if the child has any changes in weight. Emtricitabine doses are based on weight in children, and any changes may affect your child's dose. Do not take emtricitabine as your only HIV medication. HIV/AIDS is usually treated with a combination of drugs. Use all medications as directed by your doctor. Read the medication guide or patient instructions provided with each medication. Do not change your doses or medication schedule without your doctor's advice. Every person with HIV or AIDS should remain under the care of a doctor. While using emtricitabine, you may need frequent blood tests. Your kidney and liver function may also need to be checked. Get your prescription refilled before you run out of medicine completely. Your disease may become resistant to emtricitabine if you stop taking the medication even for a short time. Store capsules at room temperature away from moisture, heat, and direct light. Store liquid in the refrigerator. Do not freeze. Emtricitabine liquid kept at room temperature must be used within 3 months. If you have hepatitis B you may develop liver symptoms after you stop taking this medication, even months after stopping. Your doctor may want to check your liver function for several months after you stop using emtricitabine. What happens if I miss a dose? Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose. What happens if I overdose? Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. What should I avoid while taking emtricitabine? Taking this medication will not prevent you from passing HIV to other people. Do not have unprotected sex or share razors or toothbrushes. Talk with your doctor about safe ways to prevent HIV transmission during sex. Sharing drug or medicine needles is never safe, even for a healthy person. Emtricitabine side effects Get emergency medical help if you have signs of an allergic reaction : hives; difficult breathing; swelling of your face, lips, tongue, or throat. Early symptoms of lactic acidosis may get worse over time and this condition can be fatal. Get emergency medical help if you have even mild symptoms: muscle pain or weakness, numb or cold feeling in your arms and legs, trouble breathing, stomach pain, nausea with vomiting, fast or uneven heart rate, dizziness, or feeling very weak or tired. Call your doctor at once if you have symptoms of liver problems: swelling around your midsection, upper stomach pain, nausea, loss of appetite, dark urine, or jaundice (yellowing of the skin or eyes). Emtricitabine may increase your risk of certain infections or autoimmune disorders by changing the way your immune system works. Symptoms may occur weeks or months after you start treatment with emtricitabine. Tell your doctor if you have: signs of a new infection--fever, night sweats, swollen glands, mouth sores, diarrhea, stomach pain, weight loss; chest pain (especially when you breathe), dry cough, wheezing, feeling short of breath; cold sores, sores on your genital or anal area; rapid heart rate, feeling anxious or irritable, weakness or prickly feeling, problems with balance or eye movement; trouble speaking or swallowing, severe lower back pain, loss of bladder or bowel control; or swelling in your neck or throat (enlarged thyroid), menstrual changes, impotence, loss of interest in sex. Common side effects may include: headache, dizziness, weakness; indigestion, stomach pain, nausea, vomiting, diarrhea; sleep problems, strange dreams; rash, skin discoloration; or changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and waist). This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Side Effects (complete list) Emtricitabine dosing information Usual Adult Dose for HIV Infection: Capsules: 200 mg orally once a day Oral solution: 240 mg (24 mL) orally once a day Approved indication: In combination with other antiretroviral agents, for the treatment of HIV-1 infection Usual Adult Dose for Occupational Exposure: (Not approved by FDA) US Public Health Service working group recommendations: Capsules: 200 mg orally once a day Duration of therapy: 28 days, if tolerated Comments: -Emtricitabine plus tenofovir plus raltegravir is recommended as the preferred regimen for HIV postexposure prophylaxis; emtricitabine is also recommended as a component in various alternative regimens. -Prophylaxis should be started as soon as possible, preferably within hours after exposure. -The optimal duration of prophylaxis is unknown and may differ based on the institution's protocol. -The most current therapeutic guidelines should be consulted for more information. Usual Adult Dose for Nonoccupational Exposure: (Not approved by FDA) CDC recommendations: Capsules: 200 mg orally once a day Duration of therapy: 28 days Comments: -Emtricitabine should be used in combination with efavirenz plus (tenofovir or zidovudine), or with lopinavir-ritonavir plus zidovudine. -Prophylaxis should be started as soon as possible, within 72 hours of exposure. Usual Pediatric Dose for HIV Infection: Oral solution: 0 to 3 months: 3 mg/kg orally once a day 3 months through 17 years: 6 mg/kg orally once a day Maximum dose: 240 mg (24 mL) Capsules: 3 months through 17 years, weighing more than 33 kg, and able to swallow intact capsule: 200 mg orally once a day Approved indication: In combination with other antiretroviral agents, for the treatment of HIV-1 infection What other drugs will affect emtricitabine? Other drugs may interact with emtricitabine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using. Next Side Effects Print this page Add to My Med List More about emtricitabine Side Effects During Pregnancy or Breastfeeding Dosage Information Drug Interactions Support Group En Español 0 Reviews Add your own review/rating Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) Consumer resources Emtricitabine Capsules Emtricitabine Solution Emtricitabine (Advanced Reading) Other brands: Emtriva Professional resources Emtricitabine (AHFS Monograph) Emtricitabine (Wolters Kluwer) Related treatment guides HIV Infection Nonoccupational Exposure Occupational Exposure Where can I get more information? Your pharmacist can provide more information about emtricitabine. Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed. Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist. Copyright 1996-2012 Cerner Multum, Inc. Version: 7.01. Date modified: December 03, 2017 Last reviewed: September 19, 2017} Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Drug Class Nucleoside reverse transcriptase inhibitors (NRTIs) Related Drugs HIV Infection Truvada , Atripla , Norvir , Viread , Isentress , Prezista , Stribild , lamivudine , More... Occupational Exposure Truvada , Atripla , Viread , Isentress , lamivudine , abacavir , tenofovir , Epzicom , More... Nonoccupational Exposure Truvada , Atripla , Viread , lamivudine , abacavir , tenofovir , Epzicom , Reyataz , More... Emtricitabine Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! Help and Support Looking for answers? Ask a question or go join the emtricitabine support group to connect with others who have similar interests.} } and cannot
trudging away emtricitabine most people
EmoticonEmoticon